IBA’s Transparency Notification Explained
IBA (Ion Beam Applications) recently announced an important transparency notification regarding its shareholding structure. This announcement highlights a significant change in the ownership of shares, marking a crucial moment for the company and stakeholders involved.
Understanding the Notification
According to Article 14, paragraph 1 of the Transparency Law of May 2, 2007, IBA is required to issue notifications about major holdings in their company. This particular announcement comes after a notification received indicating that Management Anchorage SRL has fallen below the 1% ownership threshold as of February 6, 2025.
Key Details of the Notification
This transparency notification includes several key components essential for clarity and understanding. Firstly, the reason for this notification stems from the acquisition or disposal of voting securities and the resultant lowering of the minimum threshold. The details specify that Management Anchorage SRL, while notifying, has confirmed that it is not a controlled entity as defined by the relevant corporate governance laws.
Impact on Shareholders
The crossing of the ownership threshold is noteworthy. With Management Anchorage SRL's holdings dropping below 1%, this shift has implications for governance and control of the company. Transparency notifications serve to keep investors informed and maintain trust in the market’s integrity.
About IBA
Founded in Louvain-la-Neuve, Belgium, IBA is recognized globally for its innovative solutions in proton therapy technology, which is a state-of-the-art treatment method for cancer patients. Beyond its leadership in particle accelerator technology, IBA also supplies equipment and services across various sectors including industrial sterilization and radiopharmaceuticals. Currently, IBA proudly employs around 2,000 people worldwide and upholds its certification as a B Corporation, a recognition that emphasizes social and environmental responsibility.
Ansi Global Presence
As a market leader, IBA's commitment to excellence is demonstrated through its dedication to improving cancer treatments and providing top-notch solutions to healthcare providers. Additionally, with stock listed on the EURONEXT market under the ticker IBAB, it opens up avenues for investors interested in the healthcare sector.
Contact Information
For any inquiries regarding the notification or details about IBA, interested parties can reach out to:
Valérie Van Impe
Paralegal
Contact: +32479267809
Email: legal@iba-group.com
Frequently Asked Questions
What is the significance of the transparency notification?
The transparency notification informs stakeholders about changes in shareholding that can affect company governance and investor confidence.
Who was affected by this notification?
The notification specifically impacts Management Anchorage SRL, whose ownership status has changed regarding IBA shares.
How does IBA lead in proton therapy technology?
IBA is at the forefront of proton therapy, a highly advanced method for treating cancer, recognized for its precision and effectiveness.
What does being a certified B Corporation mean for IBA?
Being a certified B Corporation indicates that IBA meets rigorous social and environmental performance standards, verifying its commitment to responsible business practices.
How can one stay updated on IBA's news?
Investors and interested parties can find the latest news on IBA through their official website and financial news outlets, ensuring they remain informed about significant changes and announcements.
